Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Are Investors Undervaluing Enova International (ENVA) Right Now?
Are Investors Undervaluing Enova International (ENVA) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the

Is Fox (FOX) Stock Outpacing Its Consumer Discretionary Peers This Year?
Is Fox (FOX) Stock Outpacing Its Consumer Discretionary Peers This Year?

Investors interested in Consumer Discretionary stocks should always be looking to find the best-performing companies in the group. Fox Corporation (FOX) is a stock that can certainly grab the

Here's Why Adtalem Global Education (ATGE) is a Strong Value Stock
Here's Why Adtalem Global Education (ATGE) is a Strong Value Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Is Arcosa (ACA) Stock Outpacing Its Construction Peers This Year?
Is Arcosa (ACA) Stock Outpacing Its Construction Peers This Year?

The Construction group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Arcosa (ACA) been one of those stocks this year? Let's

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Top Sin Stocks to Buy Now for Power, Predictability & Long-Term Gains
Top Sin Stocks to Buy Now for Power, Predictability & Long-Term Gains

An updated edition of the Sept. 26, 2025, article.Investing in the stock market often brings to mind themes of growth, innovation, and long-term value creation, but beneath the surface lies a niche

NIKE vs Steven Madden: How Two Footwear Leaders Stack Up for Investors
NIKE vs Steven Madden: How Two Footwear Leaders Stack Up for Investors

In the competitive world of footwear and athleticwear, few matchups are as intriguing and revealing as the contrast between NIKE Inc. NKE and Steven Madden Ltd. SHOO. These two companies occupy very

Will RGTI's Tech Roadmap and Strong Cash Position Fuel Momentum Ahead?
Will RGTI's Tech Roadmap and Strong Cash Position Fuel Momentum Ahead?

Rigetti Computing’s RGTI third-quarter earnings depict a company that is still early in its commercial journey but is gaining traction in the right places. Revenue dipped year over year, yet

TransMedics (TMDX) Just Overtook the 20-Day Moving Average
TransMedics (TMDX) Just Overtook the 20-Day Moving Average

From a technical perspective, TransMedics (TMDX) is looking like an interesting pick, as it just reached a key level of support. TMDX recently overtook the 20-day moving average, and this suggests a

Intuitive Surgical, Inc. (ISRG) Recently Broke Out Above the 20-Day Moving Average
Intuitive Surgical, Inc. (ISRG) Recently Broke Out Above the 20-Day Moving Average

After reaching an important support level, Intuitive Surgical, Inc. (ISRG) could be a good stock pick from a technical perspective. ISRG surpassed resistance at the 20-day moving average, suggesting

After Plunging 18.2% in 4 Weeks, Here's Why the Trend Might Reverse for Phreesia (PHR)
After Plunging 18.2% in 4 Weeks, Here's Why the Trend Might Reverse for Phreesia (PHR)

Phreesia (PHR) has been beaten down lately with too much selling pressure. While the stock has lost 18.2% over the past four weeks, there is light at the end of the tunnel as it is now in oversold

After Plunging 14.4% in 4 Weeks, Here's Why the Trend Might Reverse for APTIV HLDS LTD (APTV)
After Plunging 14.4% in 4 Weeks, Here's Why the Trend Might Reverse for APTIV HLDS LTD (APTV)

A downtrend has been apparent in Aptiv PLC (APTV) lately with too much selling pressure. The stock has declined 14.4% over the past four weeks. However, given the fact that it is now in oversold

After Plunging 10.8% in 4 Weeks, Here's Why the Trend Might Reverse for Houlihan Lokey (HLI)
After Plunging 10.8% in 4 Weeks, Here's Why the Trend Might Reverse for Houlihan Lokey (HLI)

Houlihan Lokey (HLI) has been beaten down lately with too much selling pressure. While the stock has lost 10.8% over the past four weeks, there is light at the end of the tunnel as it is now in

Down 16.9% in 4 Weeks, Here's Why Conmed (CNMD) Looks Ripe for a Turnaround
Down 16.9% in 4 Weeks, Here's Why Conmed (CNMD) Looks Ripe for a Turnaround

Conmed (CNMD) has been beaten down lately with too much selling pressure. While the stock has lost 16.9% over the past four weeks, there is light at the end of the tunnel as it is now in oversold

Idexx Laboratories (IDXX) Recently Broke Out Above the 20-Day Moving Average
Idexx Laboratories (IDXX) Recently Broke Out Above the 20-Day Moving Average

From a technical perspective, Idexx Laboratories (IDXX) is looking like an interesting pick, as it just reached a key level of support. IDXX recently overtook the 20-day moving average, and this

After Plunging 17.5% in 4 Weeks, Here's Why the Trend Might Reverse for Tencent Music Entertainment Group (TME)
After Plunging 17.5% in 4 Weeks, Here's Why the Trend Might Reverse for Tencent Music Entertainment Group (TME)

Tencent Music Entertainment Group Sponsored ADR (TME) has been on a downward spiral lately with significant selling pressure. After declining 17.5% over the past four weeks, the stock looks well

Hershey's LesserEvil Buyout to Strengthen Better-for-You Snacks
Hershey's LesserEvil Buyout to Strengthen Better-for-You Snacks

The Hershey Company (HSY) has completed its acquisition of LesserEvil, a rapidly expanding organic snack maker known for bold flavor profiles and simple, high-quality ingredients. The addition of

Reasons to Add HealthEquity Stock to Your Portfolio for Now
Reasons to Add HealthEquity Stock to Your Portfolio for Now

HealthEquity, Inc. HQY has been gaining from its business model and strategy. The optimism, led by a solid second-quarter fiscal 2025 performance and strength in Health Savings Accounts (HSAs), is

Shell Signs PPAs for Renewable Power to Fuel REFHYNE 2 Project
Shell Signs PPAs for Renewable Power to Fuel REFHYNE 2 Project

Shell Energy Europe Limited, a leading subsidiary of Shell plc SHEL, has taken a monumental step in advancing renewable energy solutions through two new Power Purchase Agreements (PPAs) in Germany

Here's What Key Metrics Tell Us About Walmart (WMT) Q3 Earnings
Here's What Key Metrics Tell Us About Walmart (WMT) Q3 Earnings

For the quarter ended October 2025, Walmart (WMT) reported revenue of $179.5 billion, up 5.8% over the same period last year. EPS came in at $0.62, compared to $0.58 in the year-ago quarter.

The

Compared to Estimates, Jacobs Solutions (J) Q4 Earnings: A Look at Key Metrics
Compared to Estimates, Jacobs Solutions (J) Q4 Earnings: A Look at Key Metrics

For the quarter ended September 2025, Jacobs Solutions (J) reported revenue of $3.15 billion, up 6.6% over the same period last year. EPS came in at $1.75, compared to $1.37 in the year-ago quarter.

Compared to Estimates, Bath & Body Works (BBWI) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, Bath & Body Works (BBWI) Q3 Earnings: A Look at Key Metrics

For the quarter ended October 2025, Bath & Body Works (BBWI) reported revenue of $1.59 billion, down 1% over the same period last year. EPS came in at $0.35, compared to $0.49 in the year-ago

Maximus (MMS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Maximus (MMS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended September 2025, Maximus (MMS) reported revenue of $1.32 billion, up 0.2% over the same period last year. EPS came in at $1.62, compared to $1.46 in the year-ago quarter.

The

Wall Street Analysts See Toll Brothers (TOL) as a Buy: Should You Invest?
Wall Street Analysts See Toll Brothers (TOL) as a Buy: Should You Invest?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Is Oneok (OKE) a Buy as Wall Street Analysts Look Optimistic?
Is Oneok (OKE) a Buy as Wall Street Analysts Look Optimistic?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts